Orchard Therapeutics PLC (ORTX)

NASDAQ: ORTX · IEX Real-Time Price · USD
0.460
-0.005 (-1.12%)
At close: May 25, 2022 4:00 PM
0.473
0.013 (2.740%)
After-hours:May 25, 2022 7:50 PM EDT

Total Valuation

ORTX has a market cap or net worth of $57.90 million. The enterprise value is -$80.32 million.

Market Cap57.90M
Enterprise Value-80.32M

Important Dates

The latest earnings date was Thursday, May 12, 2022, before market open.

Last Earnings DateMay 12, 2022
Ex-Dividend Daten/a

Share Statistics

ORTX has 125.90 million shares outstanding. The number of shares has increased by 11.20% in one year.

Shares Outstanding125.90M
Shares Change (YoY)+11.20%
Shares Change (QoQ)+0.11%
Owned by Insiders (%)0.42%
Owned by Institutions (%)44.97%
Float72.71M

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ratio8.04
PB Ratio0.33
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

EV / Earningsn/a
EV / Salesn/a
EV / EBITDAn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 5.06, with a Debt / Equity ratio of 0.35.

Current Ratio5.06
Quick Ratio4.33
Debt / Equity0.35
Debt / EBITDAn/a
Debt / FCFn/a

Financial Efficiency

Return on equity (ROE) is -69.00%, which is considered low. The company has a ROIC of -55.50%.

Return on Equity (ROE)-69.00%
Return on Assets (ROA)-46.10%
Return on Capital (ROIC)-55.50%
Revenue Per Employee$27,795
Profits Per Employee-$593,429
Employee Count259
Asset Turnover0.02
Inventory Turnovern/a

Taxes

Income Tax-201,000
Effective Tax Raten/a

Stock Price Statistics

The stock price has decreased by -91.02% in the last 52 weeks. The beta is 1.19, so ORTX's price volatility has been higher than the market average.

Beta (1Y)1.19
52-Week Price Change-91.02%
50-Day Moving Average0.58
200-Day Moving Average0.99
Average Volume (30 Days)582,059

Short Selling Information

The latest short interest is 745,686, so 0.59% of the outstanding shares have been sold short.

Short Interest745,686
Short % of Shares Out0.59%
Short % of Float1.03%
Short Ratio (days to cover)1.31

Income Statement

In the last 12 months, ORTX had revenue of $7.20 million and -153.70 million in losses. Earnings per share was -$1.21.

Revenue7.20M
Gross Profit5.40M
Operating Income-142.93M
Pretax Income-153.90M
Net Income-153.70M
EBITDA-148.72M
EBIT-151.27M
Earnings Per Share (EPS)-$1.21
Full Income Statement

Balance Sheet

The company has $199.02 million in cash and $60.80 million in debt, giving a net cash position of $138.22 million or $1.10 per share.

Cash & Cash Equivalents199.02M
Total Debt60.80M
Net Cash138.22M
Net Cash Per Share$1.10
Book Value175.65M
Book Value Per Share1.40
Working Capital190.53M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$105.45 million and capital expenditures -$2.19 million, giving a free cash flow of -$107.65 million.

Operating Cash Flow-105.45M
Capital Expenditures-2.19M
Free Cash Flow-107.65M
FCF Per Sharen/a
Full Cash Flow Statement

Margins

Gross margin is 75.04%, with operating and profit margins of -1,985.37% and -2,134.99%.

Gross Margin75.04%
Operating Margin-1,985.37%
Pretax Margin-2,137.78%
Profit Margin-2,134.99%
EBITDA Margin-2,065.90%
EBIT Margin-2,101.19%
FCF Margin-1,495.28%

Dividends & Yields

ORTX does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-265.44%
FCF Yield-185.90%
Dividend Growth (YoY)n/a
Payout Ration/a
Buyback Yield-11.20%
Shareholder Yield-11.20%
Dividend Details

Analyst Forecast

The average price target for ORTX is $4.52, which is 882.82% higher than the current price. The consensus rating is "Buy".

Price Target$4.52
Price Target Difference882.82%
Analyst ConsensusBuy
Analyst Count14
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Daten/a
Split Typen/a
Split Ration/a